F
40
2
RSG
56
2
ADSK
63
2
DOW
47
3
PCG
66
5
MMM
37
2
MTCH
57
2
IVZ
48
3
FE
37
3
NRG
39
4
WEC
41
2
UPS
53
3
NDAQ
50
4
PSX
27
2
MAR
60
3
AKAM
53
5
WAT
59
4
MMC
50
4
KO
46
4
URI
39
3
F
40
2
RSG
56
2
ADSK
63
2
DOW
47
3
PCG
66
5
MMM
37
2
MTCH
57
2
IVZ
48
3
FE
37
3
NRG
39
4
WEC
41
2
UPS
53
3
NDAQ
50
4
PSX
27
2
MAR
60
3
AKAM
53
5
WAT
59
4
MMC
50
4
KO
46
4
URI
39
3
Financhill
Back

Can Fite Biofarma 10K Form

Sell
29

CANF
Can Fite Biofarma

Last Price:
$1.44
Seasonality Move:
-5.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CANF News And Ratings

See the #1 stock for the next 7 days that we like better than CANF

CANF Financial Statistics

Sales & Book Value

Annual Sales: $743K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 3.52

Profitability

Net Income (TTM): $0
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Can Fite Biofarma Earnings Forecast

Key Can Fite Biofarma Financial Ratios

  • The Selling, General & Administrative Expenses for CANF have been equal to 397.71% of Gross Profit Margin.
  • The Research & Development expenses have been 805.25% of Revenue.
  • The Interest Expense is -2.49% of Operating Income.
  • The Net Earning history of CANF is -1,027.46% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 9 years.

Can Fite Biofarma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: CANF
CUSIP: 13471N
Website: canfite.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CANF Technical Analysis vs Fundamental Analysis

Sell
29
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy or a Sell?

  • Can Fite Biofarma stock is rated a Sell
    The current Can Fite Biofarma [CANF] share price is $1.43. The Score for CANF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.